Hisato Ishikawa

469 total citations
19 papers, 159 citations indexed

About

Hisato Ishikawa is a scholar working on Rheumatology, Surgery and Epidemiology. According to data from OpenAlex, Hisato Ishikawa has authored 19 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 4 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Hisato Ishikawa's work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Hisato Ishikawa is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Hisato Ishikawa collaborates with scholars based in Japan. Hisato Ishikawa's co-authors include Naoki Ishiguro, Fumiaki Sugiura, Hiroshi Kitoh, Toshihisa Kojima, Kenya Terabe, Y. Hirano, Yasuhide Kanayama, Atsushi Kaneko, Shuji Asai and Mochihito Suzuki and has published in prestigious journals such as Scientific Reports, Acta Orthopaedica and The Journal of Rheumatology.

In The Last Decade

Hisato Ishikawa

19 papers receiving 157 citations

Peers

Countries citing papers authored by Hisato Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Hisato Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Ishikawa more than expected).

Fields of papers citing papers by Hisato Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Ishikawa. The network helps show where Hisato Ishikawa may publish in the future.

Co-authorship network of co-authors of Hisato Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Ishikawa. A scholar is included among the top collaborators of Hisato Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Ishikawa. Hisato Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Factors associated with discrepancies in disease activity as assessed by SDAI and RAPID3 in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG) 2024 ·Modern Rheumatology ·Mochihito Suzuki, Shuji Asai, Y. Ohashi, Yasumori Sobue, Hisato Ishikawa, Nobunori Takahashi, Kenya Terabe, (unknown), (unknown), Jun‐ya Hasegawa, Yusuke Ohno, (unknown), Shiro Imagama	1
2	Prevalence of social frailty in patients with rheumatoid arthritis: Data from a multicentre observational study (T-FLAG study) 2024 ·Modern Rheumatology ·Mochihito Suzuki, Shuji Asai, Y. Ohashi, Yasumori Sobue, Hisato Ishikawa, Kenya Terabe, (unknown), (unknown), Jun‐ya Hasegawa, Yusuke Ohno, (unknown), Shiro Imagama	1
3	Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients 2023 ·Clinical Rheumatology ·Yasumori Sobue, Mochihito Suzuki, Y. Ohashi, (unknown), Nobuyuki Okui, Koji Funahashi, Hisato Ishikawa, Hidenori Inoue, Shuji Asai, Kenya Terabe, Kenji Kishimoto, (unknown), (unknown), (unknown), Shiro Imagama	3
4	Validation of grip strength as a measure of frailty in rheumatoid arthritis 2022 ·Scientific Reports ·Yasumori Sobue, Mochihito Suzuki, Y. Ohashi, (unknown), Nobuyuki Okui, Koji Funahashi, Hisato Ishikawa, Hidenori Inoue, Masayo Kojima, Shuji Asai, Kenya Terabe, Kenji Kishimoto, (unknown), (unknown), Shiro Imagama, Toshihisa Kojima	6
5	Influence of frailty on patient global assessment in rheumatoid arthritis 2022 ·Geriatrics and gerontology international ·Mochihito Suzuki, Shuji Asai, Yasumori Sobue, Y. Ohashi, (unknown), Nobuyuki Okui, Hisato Ishikawa, Nobunori Takahashi, Kenya Terabe, Kenji Kishimoto, (unknown), Shiro Imagama, Toshihisa Kojima	7
6	Effectiveness of tacrolimus concomitant with biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis 2022 ·Modern Rheumatology ·Kenya Terabe, Nobunori Takahashi, Shuji Asai, Y. Hirano, Yasuhide Kanayama, Yuichiro Yabe, Takeshi Oguchi, Takayoshi Fujibayashi, Hisato Ishikawa, Masahiro Hanabayashi, Yosuke Hattori, Mochihito Suzuki, Kenji Kishimoto, Y. Ohashi, Takahiro Imaizumi, Shiro Imagama, (unknown)	1
7	Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study 2022 ·Modern Rheumatology ·Kenya Terabe, Nobunori Takahashi, Shuji Asai, Y. Hirano, Yasuhide Kanayama, Yuichiro Yabe, Takeshi Oguchi, Takayoshi Fujibayashi, Hisato Ishikawa, Masahiro Hanabayashi, Yosuke Hattori, Mochihito Suzuki, Kenji Kishimoto, Y. Ohashi, Takahiro Imaizumi, Shiro Imagama, Toshihisa Kojima	1
8	Locomotive syndrome in rheumatoid arthritis patients during the COVID-19 pandemic. 2022 ·PubMed ·Yasumori Sobue, Mochihito Suzuki, Y. Ohashi, (unknown), Nobuyuki Okui, Koji Funahashi, Hisato Ishikawa, Hidenori Inoue, Masayo Kojima, Shuji Asai, Kenya Terabe, (unknown), Kenji Kishimoto, Nobunori Takahashi, Shiro Imagama, Toshihisa Kojima	3
9	Comparison of the effects of baricitinib and tocilizumab on disease activity in patients with rheumatoid arthritis: a propensity score matching analysis 2021 ·Clinical Rheumatology ·Shuji Asai, Nobunori Takahashi, Tomonori Kobayakawa, Atsushi Kaneko, Tatsuo Watanabe, Takefumi Kato, (unknown), Hisato Ishikawa, Yutaka Yoshioka, Yasuhide Kanayama, Tsuyoshi Watanabe, Y. Hirano, Masahiro Hanabayashi, Yuichiro Yabe, Yutaka Yokota, Mochihito Suzuki, Kenya Terabe, Naoki Ishiguro, Shiro Imagama, Toshihisa Kojima	7
10	Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage 2021 ·Modern Rheumatology ·Yasumori Sobue, Mochihito Suzuki, Y. Ohashi, (unknown), Nobuyuki Okui, Koji Funahashi, Hisato Ishikawa, Shuji Asai, Kenya Terabe, Yutaka Yokota, Kenji Kishimoto, Nobunori Takahashi, Shiro Imagama, Toshihisa Kojima	9
11	Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry 2020 ·Scientific Reports ·Nobunori Takahashi, Shuji Asai, Tomonori Kobayakawa, Atsushi Kaneko, Tatsuo Watanabe, Takefumi Kato, (unknown), Hisato Ishikawa, Yutaka Yoshioka, Yasuhide Kanayama, Tsuyoshi Watanabe, Y. Hirano, Masahiro Hanabayashi, Yuichiro Yabe, Yutaka Yokota, Mochihito Suzuki, Yasumori Sobue, Kenya Terabe, Naoki Ishiguro, Toshihisa Kojima	20
12	High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab 2017 ·Modern Rheumatology ·Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Y. Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Takeshi Oguchi, Yasuhide Kanayama, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Tomone Shioura, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi, Naoki Ishiguro	10
13	Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study 2016 ·The Journal of Rheumatology ·Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Y. Hirano, Takayoshi Fujibayashi, Kenya Terabe, Yuichiro Yabe, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Yasuhide Kanayama, Takeshi Oguchi, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi, Naoki Ishiguro	3
14	Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies 2013 ·Clinical Rheumatology ·Masatoshi Hayashi, Tomonori Kobayakawa, (unknown), (unknown), Hisato Ishikawa, (unknown)	1
15	Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice 2012 ·Modern Rheumatology ·Toshihisa Kojima, Atsushi Kaneko, Y. Hirano, Hisato Ishikawa, Hiroyuki Miyake, Hideki Takagi, Yuichiro Yabe, Takefumi Kato, Kenya Terabe, (unknown), Hiroki Tsuchiya, Tomone Shioura, Koji Funahashi, Masatoshi Hayashi, Daizo Kato, Hiroyuki Matsubara, Naoki Ishiguro	13
16	Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice 2011 ·Modern Rheumatology ·Toshihisa Kojima, Atsushi Kaneko, Y. Hirano, Hisato Ishikawa, Hiroyuki Miyake, Hideki Takagi, Yuichiro Yabe, Takefumi Kato, Kenya Terabe, (unknown), Hiroki Tsuchiya, Tomone Shioura, Koji Funahashi, Masatoshi Hayashi, Daizo Kato, Hiroyuki Matsubara, Naoki Ishiguro	18
17	A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid 2009 ·Modern Rheumatology ·Y. Hirano, Toshihisa Kojima, Yasuhide Kanayama, Hisato Ishikawa, Naoki Ishiguro	8
18	A case of lung tuberculosis in a patient with rheumatoid arthritis treated with infliximab after antituberculosis chemoprophylaxis with isoniazid 2009 ·Modern Rheumatology ·Y. Hirano, Toshihisa Kojima, Yasuhide Kanayama, Hisato Ishikawa, Naoki Ishiguro	3
19	The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages 2007 ·Acta Orthopaedica ·Hisato Ishikawa, Hiroshi Kitoh, Fumiaki Sugiura, Naoki Ishiguro	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact